Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
2.910
+0.020 (0.69%)
At close: Jan 21, 2025, 4:00 PM
2.930
+0.020 (0.69%)
After-hours: Jan 21, 2025, 6:04 PM EST
Prime Medicine Employees
Prime Medicine had 234 employees as of December 31, 2023. The number of employees increased by 59 or 33.71% compared to the previous year.
Employees
234
Change (1Y)
59
Growth (1Y)
33.71%
Revenue / Employee
$3,419
Profits / Employee
-$936,962
Market Cap
371.30M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 234 | 59 | 33.71% |
Dec 31, 2022 | 175 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
PRME News
- 2 months ago - Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies - Seeking Alpha
- 2 months ago - Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics - GlobeNewsWire
- 2 months ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress - GlobeNewsWire
- 3 months ago - Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings - GlobeNewsWire
- 4 months ago - Crude Oil Moves Higher; Prime Medicine Shares Spike Higher - Benzinga
- 4 months ago - Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline - Benzinga
- 4 months ago - Prime Medicine Unveils Strategically Focused Pipeline - GlobeNewsWire